Korro Bio adds AATD treatment candidate to pipeline
Korro Bio adds AATD treatment candidate to pipeline Source link
Featured
treatment
LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment
Austin, Texas, United States, February 9th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts
NRx Pharmaceuticals (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
Austin, Texas, United States, December 3rd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its
Biotech Stocks Positioned to Transform Treatment With Next-Gen Therapeutics
Naples, FL, September 26th, 2025, FinanceWire Naples, FL, September 26th, 2025, NewsDirect Biotech is entering a new era of drug
Featured
IO Biotech to announce Phase 3 melanoma treatment results
IO Biotech to announce Phase 3 melanoma treatment results Source link
Featured
IO Biotech to announce Phase 3 melanoma treatment results
IO Biotech to announce Phase 3 melanoma treatment results Source link
Featured
VOXZOGO shows promise in tibial bowing treatment
VOXZOGO shows promise in tibial bowing treatment Source link
Drug Tariffs Could Raise Cancer Treatment Cost By $10,000, Analysis Finds
Key Takeaways Cancer treatment costs could soar under a proposal by President Donald Trump to raise tariffs by 25% on
Featured
Hoth reports progress in GIST treatment with HT-KIT
Hoth reports progress in GIST treatment with HT-KIT Source link